Edwards Lifesciences buys VC-backed Harpoon for up to $250 mln

Edwards Lifesciences has acquired Harpoon Medical Inc, a provider of beating-heart repair for degenerative mitral regurgitation, for up to $250 million. Harpoon Medical was backed by Epidarex Capital.

Byiris dorbian

7 December 2017•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Managers North America US Healthcare M&A Deals Briefs